Mobile applications as good intervention tools for individuals with depression

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F17%3A50013686" target="_blank" >RIV/62690094:18450/17:50013686 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00179906:_____/17:10372933

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Mobile applications as good intervention tools for individuals with depression

Popis výsledku v původním jazyce

At present mental disorders affect approximately 450 million people around the world. Depressive disorder is probably one of the most serious disorders and as a type of chronic disease, it represents a global threat and burdens economic and social systems of both individuals and governments worldwide. One of these most recent non-pharmacological approaches is also the so-called mHealth (mobile health), the use of mobile devices for the practice of medicine and public health, which proves to be effective particularly in the early stages of depression. The purpose of this article is to explore the most recent randomized controlled trial studies which indicate efficacy of the use of mobile applications in the detection, diagnostics or treatment of depression. The methods used in this study include a method of literature search of the studies focused on the impacts of individual applications for people with depression and on the specification of criteria evaluating quality of these applications. The findings of the randomized controlled trials (RCT) show that there is a big potential of mobile applications in the detection, diagnostics, and treatment of depression, particularly in mild and moderate stages of the disease. They seem to be especially relevant for self-monitoring of depressive symptoms in the early stages of depression. There is an urgent need of more longitudinal RCT in this field in order to prove conclusive efficacy of these mobile applications in the treatment of depression. The authors list the main strengths and weaknesses of mobile applications in the detection, diagnostics, and treatment of depression.

Název v anglickém jazyce

Mobile applications as good intervention tools for individuals with depression

Popis výsledku anglicky

At present mental disorders affect approximately 450 million people around the world. Depressive disorder is probably one of the most serious disorders and as a type of chronic disease, it represents a global threat and burdens economic and social systems of both individuals and governments worldwide. One of these most recent non-pharmacological approaches is also the so-called mHealth (mobile health), the use of mobile devices for the practice of medicine and public health, which proves to be effective particularly in the early stages of depression. The purpose of this article is to explore the most recent randomized controlled trial studies which indicate efficacy of the use of mobile applications in the detection, diagnostics or treatment of depression. The methods used in this study include a method of literature search of the studies focused on the impacts of individual applications for people with depression and on the specification of criteria evaluating quality of these applications. The findings of the randomized controlled trials (RCT) show that there is a big potential of mobile applications in the detection, diagnostics, and treatment of depression, particularly in mild and moderate stages of the disease. They seem to be especially relevant for self-monitoring of depressive symptoms in the early stages of depression. There is an urgent need of more longitudinal RCT in this field in order to prove conclusive efficacy of these mobile applications in the treatment of depression. The authors list the main strengths and weaknesses of mobile applications in the detection, diagnostics, and treatment of depression.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30301 - Social biomedical sciences (includes family planning, sexual health, psycho-oncology, political and social effects of biomedical research)

Projekt

<a href="/cs/project/GA17-03037S" target="_blank" >GA17-03037S: Hodnocení investic do vývoje zdravotních prostředků</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Česká a slovenská farmacie

ISSN

1210-7816

e-ISSN

—

Svazek periodika

66

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

7

Strana od-do

55-61

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85029620219